Sarah is the first employee and Director of Research at Courier Therapeutics, a cancer immunotherapy startup, and Director of Research at Resonant Therapeutics, a cancer therapeutics platform technology company. She has participated in enventure since 2013, coming on as a core member in 2015 and launching the Foundations workshop series to provide in-depth entrepreneurship education to the TMC community. Sarah graduated with her PhD in Molecular and Cellular Biology at Baylor College of Medicine.

Baylor College of Medicine
TMC Innovation